# SSAT061: PK of DTG and EVT/COBI in Healthy Volunteers

> **NCT02219217** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 17 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Dolutegravir, Elvitegravir and Cobicistat

## Key facts

- **NCT ID:** NCT02219217
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02219217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02219217, "SSAT061: PK of DTG and EVT/COBI in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02219217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*